Literature DB >> 14521520

The influence of STAT5 antisense oligonucleotides on the proliferation and apoptosis of selected human leukaemic cell lines.

M Baśkiewicz-Masiuk1, M Masiuk, B Machaliński.   

Abstract

The signal transducers and activators of transcription--STAT5A and STAT5B--take part in the regulation of many essential physiopathological processes. They influence the cell cycle, apoptosis and the proliferation of different types of cell lines. The STAT5 proteins are induced in response to multiple haematopoietic cytokines. Because they are constitutively active in certain haemato-oncologic diseases, it is also suggested that they play an important role in leukaemogenesis. However, function of these proteins in haematopoietic cell transformation and proliferation is not clear. The aim of this study was to evaluate the impact of perturbation of STAT5 expression [using oligodeoxynucleotide (ODN) against STAT5 mRNA], on the clonogenicity and survival of selected human leukaemic cell lines, HEL, HL-60, K562, TF-1. We analysed the effect of ODN pre-treatment on the cell clonogenicity in methylcellulose cultures according to the time and the temperature of exposure. Moreover, we attempted to estimate apoptosis induced in examined cells, by flow cytometry using combined Annexin V-PI staining and the TUNEL method. We also applied the RT-PCR method to analyse Bax and Bcl-xL gene expression. We found that the perturbation of STAT5 expression with antisense oligonucleotides caused a decrease in the proliferative potential of human K562 and TF-1 cell lines. Also, we observed higher induction of apoptotic cell death in the K562 and TF-1 cells incubated with the antisense STAT5A ODNs. We did not notice any impact of ODNs on the HL-60 and HEL cells. Our studies using STAT5 antisense oligonucleotides showed that these proteins may be critical in the regulation of growth and apoptosis of some types of leukaemic blasts.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14521520      PMCID: PMC6495883          DOI: 10.1046/j.1365-2184.2003.00283.x

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  46 in total

1.  STAT5 activation contributes to growth and viability in Bcr/Abl-transformed cells.

Authors:  C Sillaber; F Gesbert; D A Frank; M Sattler; J D Griffin
Journal:  Blood       Date:  2000-03-15       Impact factor: 22.113

2.  Antiapoptotic activity of Stat5 required during terminal stages of myeloid differentiation.

Authors:  M Kieslinger; I Woldman; R Moriggl; J Hofmann; J C Marine; J N Ihle; H Beug; T Decker
Journal:  Genes Dev       Date:  2000-01-15       Impact factor: 11.361

Review 3.  The JAK-STAT pathway: signal transduction involved in proliferation, differentiation and transformation.

Authors:  R M Weber-Nordt; R Mertelsmann; J Finke
Journal:  Leuk Lymphoma       Date:  1998-02

4.  Dominant negative mutants implicate STAT5 in myeloid cell proliferation and neutrophil differentiation.

Authors:  R L Ilaria; R G Hawley; R A Van Etten
Journal:  Blood       Date:  1999-06-15       Impact factor: 22.113

5.  Bcr/Abl activates transcription of the Bcl-X gene through STAT5.

Authors:  F Gesbert; J D Griffin
Journal:  Blood       Date:  2000-09-15       Impact factor: 22.113

Review 6.  STAT proteins: novel molecular targets for cancer drug discovery.

Authors:  J Turkson; R Jove
Journal:  Oncogene       Date:  2000-12-27       Impact factor: 9.867

7.  Differential function of STAT5 isoforms in head and neck cancer growth control.

Authors:  Paul L Leong; Sichuan Xi; Stephanie D Drenning; Kevin F Dyer; Abbey L Wentzel; Edwina C Lerner; Thomas E Smithgall; Jennifer Rubin Grandis
Journal:  Oncogene       Date:  2002-04-25       Impact factor: 9.867

8.  Oligodeoxynucleotide-mediated inhibition of c-myb gene expression in autografted bone marrow: a pilot study.

Authors:  Selina M Luger; Stephen G O'Brien; Janina Ratajczak; Mariusz Z Ratajczak; Rosemarie Mick; Edward A Stadtmauer; Peter C Nowell; John M Goldman; Alan M Gewirtz
Journal:  Blood       Date:  2002-02-15       Impact factor: 22.113

9.  Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease.

Authors:  J E Durbin; R Hackenmiller; M C Simon; D E Levy
Journal:  Cell       Date:  1996-02-09       Impact factor: 41.582

10.  STAT-related transcription factors are constitutively activated in peripheral blood cells from acute leukemia patients.

Authors:  V Gouilleux-Gruart; F Gouilleux; C Desaint; J F Claisse; J C Capiod; J Delobel; R Weber-Nordt; I Dusanter-Fourt; F Dreyfus; B Groner; L Prin
Journal:  Blood       Date:  1996-03-01       Impact factor: 22.113

View more
  7 in total

1.  The influence of antisense oligonucleotides against STAT5 on the regulation of normal haematopoiesis in a bone marrow model.

Authors:  M Baśkiewicz-Masiuk; M Paczkowski; B Machaliński
Journal:  Cell Prolif       Date:  2004-06       Impact factor: 6.831

2.  Suppression of STAT5A and STAT5B chronic myeloid leukemia cells via siRNA and antisense-oligonucleotide applications with the induction of apoptosis.

Authors:  Burçin Tezcanlı Kaymaz; Nur Selvi; Aysun Adan Gokbulut; Cağdaş Aktan; Cumhur Gündüz; Güray Saydam; Fahri Sahin; Vildan Bozok Cetintaş; Yusuf Baran; Buket Kosova
Journal:  Am J Blood Res       Date:  2013-01-17

3.  Expression of activated STAT5 in neoplastic mast cells in systemic mastocytosis: subcellular distribution and role of the transforming oncoprotein KIT D816V.

Authors:  Christian Baumgartner; Sabine Cerny-Reiterer; Karoline Sonneck; Matthias Mayerhofer; Karoline V Gleixner; Richard Fritz; Marc Kerenyi; Cedric Boudot; Fabrice Gouilleux; Jan-Wilhelm Kornfeld; Christian Sillaber; Richard Moriggl; Peter Valent
Journal:  Am J Pathol       Date:  2009-11-05       Impact factor: 4.307

4.  The influence of 3,3',5-triiodo-L-thyronine on human haematopoiesis.

Authors:  K Grymuła; E Paczkowska; V Dziedziejko; M Baśkiewicz-Masiuk; M Kawa; B Baumert; Z Celewicz; E Gawrych; B Machaliński
Journal:  Cell Prolif       Date:  2007-06       Impact factor: 6.831

5.  Dexamethasone inhibits camptothecin-induced apoptosis in C6-glioma via activation of Stat5/Bcl-xL pathway.

Authors:  Yi-Hua Qian; Qingli Xiao; Hong Chen; Jan Xu
Journal:  Biochim Biophys Acta       Date:  2009-02-07

6.  Stat5 Exerts Distinct, Vital Functions in the Cytoplasm and Nucleus of Bcr-Abl+ K562 and Jak2(V617F)+ HEL Leukemia Cells.

Authors:  Axel Weber; Corina Borghouts; Christian Brendel; Richard Moriggl; Natalia Delis; Boris Brill; Vida Vafaizadeh; Bernd Groner
Journal:  Cancers (Basel)       Date:  2015-03-19       Impact factor: 6.639

7.  STAT5 inhibition induces TRAIL/DR4 dependent apoptosis in peripheral T-cell lymphoma.

Authors:  Haley M Simpson; Aki Furusawa; Kavitha Sadashivaiah; Curt I Civin; Arnob Banerjee
Journal:  Oncotarget       Date:  2018-03-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.